Dafna Capital Management LLC Larimar Therapeutics, Inc. Transaction History

Dafna Capital Management LLC

$389 Million
Q3 2024

A detailed history of Dafna Capital Management LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 494,274 shares of LRMR stock, worth $3.31 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares

494,274

Previous 639,974 22.77%

Holding current value

$3.31 Million

Previous $4.64 Million 30.22%

% of portfolio

0.83%

Previous 1.19%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.3 - $10.68 $917,910 - $1.56 Million	-145,700 Reduced 22.77%	494,274 $3.24 Million
Q2 2024 Aug 14, 2024	SELL	$6.33 - $9.89 $103,805 - $162,186	-16,399 Reduced 2.5%	639,974 $4.64 Million
Q1 2024 May 15, 2024	BUY	$4.2 - $13.28 $1.4 Million - $4.42 Million	332,500 Added 102.66%	656,373 $4.98 Million
Q4 2023 Feb 14, 2024	SELL	$2.35 - $4.71 $8,225 - $16,485	-3,500 Reduced 1.07%	323,873 $1.47 Million
Q3 2023 Nov 14, 2023	SELL	$3.08 - $4.49 $70,840 - $103,270	-23,000 Reduced 6.56%	327,373 $1.29 Million
Q2 2023 Aug 14, 2023	BUY	$3.13 - $5.27 $355,255 - $598,145	113,500 Added 47.92%	350,373 $1.1 Million
Q1 2023 May 15, 2023	SELL	$4.0 - $6.68 $945,052 - $1.58 Million	-236,263 Reduced 49.94%	236,873 $1.07 Million
Q4 2022 Feb 14, 2023	SELL	$2.73 - $5.08 $278,077 - $517,448	-101,860 Reduced 17.71%	473,136 $1.95 Million
Q3 2022 Nov 14, 2022	BUY	$1.53 - $3.64 $803,250 - $1.91 Million	525,000 Added 1050.08%	574,996 $1.84 Million
Q1 2022 May 16, 2022	SELL	$3.65 - $10.84 $73,660 - $218,762	-20,181 Reduced 28.76%	49,996 $202,000
Q4 2021 Feb 14, 2022	BUY	$8.86 - $13.47 $50,413 - $76,644	5,690 Added 8.82%	70,177 $757,000
Q3 2021 Nov 15, 2021	SELL	$9.61 - $15.11 $120,125 - $188,875	-12,500 Reduced 16.24%	64,487 $744,000
Q2 2021 Aug 16, 2021	SELL	$8.0 - $15.2 $35,560 - $67,564	-4,445 Reduced 5.46%	76,987 $756,000
Q1 2021 May 17, 2021	BUY	$14.61 - $22.19 $482,188 - $732,358	33,004 Added 68.15%	81,432 $1.19 Million
Q4 2020 Feb 16, 2021	SELL	$14.28 - $25.06 $438,781 - $770,018	-30,727 Reduced 38.82%	48,428 $1.04 Million
Q3 2020 Nov 16, 2020	SELL	$10.5 - $17.6 $494,613 - $829,065	-47,106 Reduced 37.31%	79,155 $1.2 Million
Q2 2020 Aug 14, 2020	BUY	$0.72 - $16.76 $90,907 - $2.12 Million	126,261 New	126,261 $1.62 Million

Others Institutions Holding LRMR

# of Institutions

127

Shares Held

67.2M

Call Options Held

280K

Put Options Held

76.3K

View Full List

About Larimar Therapeutics, Inc.

Ticker LRMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,269,200
Market Cap $289M
Description
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...

More about LRMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Larimar Therapeutics, Inc. Transaction History